Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors

British Journal of Haematology

Volumn 111, Issue 3, 2000, Pages 974-979

  Hough, R E ^a   Hampton, K K ^a   Preston, F E ^a   Channer, K S ^a   West, J ^a   Makris, M ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Haemophilia; Myocardial infarction; Prothrombin complex concentrates; Recombinant factor VIIa

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; ATHEROMA; BLEEDING; CARDIOVASCULAR RISK; CASE REPORT; HEART INFARCTION; HEMOPHILIA; HUMAN; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; THROMBOSIS; TRANSFUSION;

ABDOMEN; ADULT; AGED; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; FACTOR VIIA; FACTOR VIII; HEMARTHROSIS; HEMATOMA; HEMOPHILIA A; HUMANS; KNEE JOINT; MALE; MYOCARDIAL INFARCTION; RECOMBINANT PROTEINS;

EID: 0034492194     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02463.x     Document Type: Article

References (22)

1. Hazards of prothrombin-complex concentrates in treatment of hemophilia
2. Acute myocardial infarction in a young hemophiliac patient during therapy with factor IX concentrate and epsilon aminocaproic acid
3. Tissue-factor antigen and activity in human coronary atherosclerotic plaques
4. Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor
5. Disseminated intravascular coagulation and myocardial infarction in a haemophilia B patient during therapy with prothrombin complex concentrates
6. Myocardial infarction after factor IX therapy
7. Acute myocardial infarction, non-bacterial thrombotic endocarditis, and disseminated intravascular coagulation in a severe hemophiliac
8. Fatal myocardial necrosis associated with prothrombin-complex concentrate therapy in haemophilia A
9. Magnetic resonance imaging of myocardial infarction during prothrombin complex concentrate therapy of haemophilia A
10. Treatment of patients with factor VIII and factor IX inhibitors with a special focus on the use recombinant factor VIIa
11. Complications of therapy in haemophilia
12. Acute myocardial infarction complicating prothrombin complex concentrate therapy in an 8-year-old boy with hemophilia A and factor VIII inhibitor
13. Myocardial necrosis after therapy with prothrombin-complex concentrate
14. Thrombogenicity associated with factor IX complex concentrates
15. Prediction and management of adverse events associated with the use of factor IX complex concentrates
16. Efficacy of prothrombin-complex concentrates in haemophiliacs with antibodies to factor VIII
17. Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor
18. Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor
19. Haemophilia protects against ischaemic heart disease: A study of risk factors
20. Myocardial infarction complicating activated prothrombin complex concentrate substitution in patient with haemophilia A
21. Vascular lesions in Hemophilia B
22. Fatal myocardial infarction following therapy with prothrombin complex concentrates in a young men with henmophilia A